Department of Life and Environmental Sciences, Polytechnic University of Marche, via Brecce Bianche, 60131, Ancona, Italy.
Department of Earth, Environmental and Life Sciences, University of Genoa, Corso Europa, 26, 16132, Genoa, Italy.
BMC Infect Dis. 2018 Dec 27;18(1):701. doi: 10.1186/s12879-018-3612-9.
Routine culture-based diagnosis of Pseudomonas aeruginosa lung infection in Cystic Fibrosis (CF) patients can be hampered by the phenotypic variability of the microorganism, including its transition to a Viable But Non-Culturable (VBNC) state. The aim of this study was to validate an ecfX-targeting qPCR protocol developed to detect all viable P. aeruginosa bacteria and to identify VBNC forms in CF sputum samples.
The study involved 115 P. aeruginosa strains of different origins and 10 non-P. aeruginosa strains and 88 CF sputum samples, 41 Culture-Positive (CP) and 47 Culture-Negative (CN). Spiking assays were performed using scalar dilutions of a mixture of live and dead P. aeruginosa ATCC 9027 and a pooled P. aeruginosa-free sputum batch. Total DNA from sputum samples was extracted by a commercial kit, whereas a crude extract was obtained from the broth cultures. Extracellular DNA (eDNA) interference was evaluated by comparing the qPCR counts obtained from DNase-treated and untreated aliquots of the same samples. The statistical significance of the results was assessed by the Wilcoxon test and Student's t test.
The newly-developed qPCR protocol identified 96.6% of the P. aeruginosa isolates; no amplification was obtained with strains belonging to different species. Spiking assays supported protocol reliability, since counts always matched the amount of live bacteria, thus excluding the interference of dead cells and eDNA. The protocol sensitivity threshold was 70 cells/ml of the original sample. Moreover, qPCR detected P. aeruginosa in 9/47 CN samples and showed higher bacterial counts compared with the culture method in 10/41 CP samples.
Our findings demonstrate the reliability of the newly-developed qPCR protocol and further highlight the need for harnessing a non-culture approach to achieve an accurate microbiological diagnosis of P. aeruginosa CF lung infection and a greater understanding of its evolution.
在囊性纤维化 (CF) 患者中,基于常规培养的铜绿假单胞菌肺部感染诊断可能会受到微生物表型变异的阻碍,包括其向存活但不可培养 (VBNC) 状态的转变。本研究旨在验证一种针对 ecfX 靶标的 qPCR 方案,该方案旨在检测所有存活的铜绿假单胞菌细菌,并识别 CF 痰样本中的 VBNC 形式。
该研究涉及来自不同来源的 115 株铜绿假单胞菌菌株和 10 株非铜绿假单胞菌菌株以及 88 例 CF 痰样本,其中 41 例为培养阳性 (CP),47 例为培养阴性 (CN)。通过对活死铜绿假单胞菌 ATCC 9027 混合物的标度稀释和一个无铜绿假单胞菌的混合痰批次进行了掺入实验。通过商业试剂盒从痰样本中提取总 DNA,而从肉汤培养物中获得粗提取物。通过比较同一样本的 DNase 处理和未处理等分样的 qPCR 计数来评估细胞外 DNA (eDNA) 的干扰。通过 Wilcoxon 检验和学生 t 检验评估结果的统计学意义。
新开发的 qPCR 方案可识别 96.6%的铜绿假单胞菌分离株; 不同种属的菌株均未扩增。掺入实验支持方案的可靠性,因为计数总是与活细菌的数量相匹配,从而排除了死细胞和 eDNA 的干扰。方案的灵敏度阈值为原始样本的 70 个细胞/ml。此外,qPCR 在 9/47 CN 样本中检测到铜绿假单胞菌,并且在 10/41 CP 样本中与培养方法相比,显示出更高的细菌计数。
我们的研究结果证明了新开发的 qPCR 方案的可靠性,进一步强调了需要采用非培养方法来实现铜绿假单胞菌 CF 肺部感染的准确微生物学诊断,并更好地了解其演变。